Relay Therapeutics, Inc. (RLAY) Net margin 2020–2025
Relay Therapeutics, Inc. (RLAY) net profit margin by fiscal year — reported net income divided by reported revenue.
-1800.6%FY2025 · since FY2020: -63.4% → -1800.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1800.6% | +1574.1 pp |
| FY2024 | -3374.7% | -2036.1 pp |
| FY2023 | -1338.7% | +19697.5 pp |
| FY2022 | -21036.1% | -9023.2 pp |
| FY2021 | -12012.9% | -11949.5 pp |
| FY2020 | -63.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →